First Time Loading...

Agilent Technologies Inc
NYSE:A

Watchlist Manager
Agilent Technologies Inc Logo
Agilent Technologies Inc
NYSE:A
Watchlist
Price: 136.37 USD -0.81% Market Closed
Updated: Apr 26, 2024

EBITDA Margin
Agilent Technologies Inc

23.4%
Current
26%
Average
9.3%
Industry
Positive for the last year
23.4%
Positive average
26%
Worse than average
Better than industry value

EBITDA Margin Across Competitors

EBITDA Margin Comparison
Agilent Technologies Inc Competitors

Country Company Market Cap EBITDA
Margin
US
Agilent Technologies Inc
NYSE:A
40B USD
23%
US
Thermo Fisher Scientific Inc
NYSE:TMO
221.1B USD
25%
US
Danaher Corp
NYSE:DHR
181.7B USD
31%
US
IQVIA Holdings Inc
NYSE:IQV
42.5B USD
21%
CH
Lonza Group AG
SIX:LONN
37.1B CHF
29%
KR
Samsung Biologics Co Ltd
KRX:207940
55.5T KRW
43%
US
West Pharmaceutical Services Inc
NYSE:WST
27.1B USD
29%
US
Mettler-Toledo International Inc
NYSE:MTD
26.5B USD
32%
IE
ICON PLC
NASDAQ:ICLR
24.8B USD
20%
FR
Sartorius Stedim Biotech SA
PAR:DIM
18.7B EUR
24%
US
Illumina Inc
NASDAQ:ILMN
19.2B USD
8%
Agilent Technologies Inc
NYSE:A
Country US
Market Cap 40B USD
EBITDA Margin
23%
Thermo Fisher Scientific Inc
NYSE:TMO
Country US
Market Cap 221.1B USD
EBITDA Margin
25%
Danaher Corp
NYSE:DHR
Country US
Market Cap 181.7B USD
EBITDA Margin
31%
IQVIA Holdings Inc
NYSE:IQV
Country US
Market Cap 42.5B USD
EBITDA Margin
21%
Lonza Group AG
SIX:LONN
Country CH
Market Cap 37.1B CHF
EBITDA Margin
29%
Samsung Biologics Co Ltd
KRX:207940
Country KR
Market Cap 55.5T KRW
EBITDA Margin
43%
West Pharmaceutical Services Inc
NYSE:WST
Country US
Market Cap 27.1B USD
EBITDA Margin
29%
Mettler-Toledo International Inc
NYSE:MTD
Country US
Market Cap 26.5B USD
EBITDA Margin
32%
ICON PLC
NASDAQ:ICLR
Country IE
Market Cap 24.8B USD
EBITDA Margin
20%
Sartorius Stedim Biotech SA
PAR:DIM
Country FR
Market Cap 18.7B EUR
EBITDA Margin
24%
Illumina Inc
NASDAQ:ILMN
Country US
Market Cap 19.2B USD
EBITDA Margin
8%

Profitability Report

View the profitability report to see the full profitability analysis for Agilent Technologies Inc.

Full Profitability Report

See Also

Summary
A intrinsic value, competitors valuation, and company profile.
DCF Valuation
A stock valuation using Discount Cash Flow valuation method.
Relative Valuation
A stock valuation using valuation multiples.
Wall Street Estimates
A price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
A stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is EBITDA Margin?
What is the EBITDA Margin of Agilent Technologies Inc?

Based on Agilent Technologies Inc's most recent financial statements, the company has EBITDA Margin of 23.4%.

ALPHA SPREAD
Join more than 131,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.